ArticleNeoplasia (New York, N.Y.)2008

Hypoxia-specific drug tirapazamine does not abrogate hypoxic tumor cells in combination therapy with irinotecan and methylselenocysteine in well-differentiated human head and neck squamous cell carcinoma a253 xenografts.

Arup Bhattacharya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.